Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Cancers|March 29, 2023
Post-CDK 4/6 Inhibitor Therapy: Current Agents and Novel TargetsNadia Ashai, Sandra M SwainCurrent Treatment Options in Oncology|May 31, 2019
Multimodality Management of Localized Biliary CancerNadia Ashai, Preethi Prasad, Lakshmi RajdevExpert Opinion on Pharmacotherapy|November 16, 2018
Nanoparticle albumin bound-paclitaxel for treatment of advanced non-small cell lung cancer: an evaluation of the clinical evidenceDiego Adrianzen Herrera, Nadia Ashai, Roman Perez-Soler, et al.Pharmacogenomics|November 9, 2023
Pharmacogenomic testing in oncology: a health system's approach to identify oncology provider perspectivesMeghna Bhatt, Beth N Peshkin, Sadaf Kazi, et al.Proceedings of the National Academy of Sciences of the United States of America|September 23, 2021
Functional succinate dehydrogenase deficiency is a common adverse feature of clear cell renal cancerRitesh K Aggarwal, Rebecca A Luchtel, Venkata Machha, et al.Research Square|August 26, 2024
Pharmacokinetics and Pharmacogenomics of Ribociclib in Black Patients with Metastatic Breast Cancer: The LEANORA studySandra Swain, Ilana Schlam, D Max Smith, et al.Clinical Lymphoma, Myeloma & Leukemia|December 19, 2020
Multiple Myeloma in Hispanics: Incidence, Characteristics, Survival, Results of Discovery, and Validation Using Real-World and Connect MM Registry DataGurbakhash Kaur, Mateo Mejia Saldarriaga, Nishi Shah, et al.NPJ Breast Cancer|September 30, 2024
Pharmacokinetics and pharmacogenomics of ribociclib in black patients with metastatic breast cancer the LEANORA studyIlana Schlam, D Max Smith, Cody Peer, et al.Pageof 1